1. Home
  2. GERN vs LXU Comparison

GERN vs LXU Comparison

Compare GERN & LXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • LXU
  • Stock Information
  • Founded
  • GERN 1990
  • LXU 1968
  • Country
  • GERN United States
  • LXU United States
  • Employees
  • GERN N/A
  • LXU N/A
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • LXU Major Chemicals
  • Sector
  • GERN Health Care
  • LXU Industrials
  • Exchange
  • GERN Nasdaq
  • LXU Nasdaq
  • Market Cap
  • GERN 700.6M
  • LXU 612.4M
  • IPO Year
  • GERN 1996
  • LXU 1969
  • Fundamental
  • Price
  • GERN $1.46
  • LXU $8.19
  • Analyst Decision
  • GERN Buy
  • LXU Buy
  • Analyst Count
  • GERN 8
  • LXU 3
  • Target Price
  • GERN $3.71
  • LXU $10.08
  • AVG Volume (30 Days)
  • GERN 12.0M
  • LXU 459.5K
  • Earning Date
  • GERN 08-06-2025
  • LXU 07-29-2025
  • Dividend Yield
  • GERN N/A
  • LXU N/A
  • EPS Growth
  • GERN N/A
  • LXU N/A
  • EPS
  • GERN N/A
  • LXU N/A
  • Revenue
  • GERN $164,447,000.00
  • LXU $538,851,000.00
  • Revenue This Year
  • GERN $159.14
  • LXU $11.05
  • Revenue Next Year
  • GERN $52.76
  • LXU $1.97
  • P/E Ratio
  • GERN N/A
  • LXU N/A
  • Revenue Growth
  • GERN 11877.20
  • LXU 2.60
  • 52 Week Low
  • GERN $1.09
  • LXU $4.88
  • 52 Week High
  • GERN $4.83
  • LXU $9.68
  • Technical
  • Relative Strength Index (RSI)
  • GERN 59.63
  • LXU 57.02
  • Support Level
  • GERN $1.26
  • LXU $7.64
  • Resistance Level
  • GERN $1.55
  • LXU $7.92
  • Average True Range (ATR)
  • GERN 0.09
  • LXU 0.29
  • MACD
  • GERN 0.02
  • LXU 0.05
  • Stochastic Oscillator
  • GERN 75.00
  • LXU 99.05

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

Share on Social Networks: